Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-19 | New | $40,251,391 | $40,251,391 | Equity Only | 06b | SEC link |
| 2023-11-20 | New | $2,000,000 | $2,000,000 | Debt Only | 06c | SEC link |
| 2022-08-08 | New | $2,000,000 | $2,000,000 | Debt Only | 06b | SEC link |
| 2020-06-25 | New | $4,000,000 | $4,000,000 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Francis Duhay | Director |
| Bruce Feuchter | Executive |
| Steven Gex | Director |
| Christopher Martin | Director |
| J. Avi Roop | Director |
| J.Avi Roop | Director |
| William Starling | Director |
| William N. Starling, Jr. | Director |
| Francis Suhay | Director |
| George Wallace | Director, Executive |